| Tag | Content |
|---|
EnhancerAtlas ID | HS133-22023 |
Organism | Homo sapiens |
Tissue/cell | melanoma |
Coordinate | chr3:16443970-16444970 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NFE2L1 | MA0089.2 | chr3:16444137-16444152 | AATGATGAGTCATTT | - | 6.18 | | RREB1 | MA0073.1 | chr3:16443978-16443998 | GGTTTGTGGGTGGGTTCTGG | - | 6.26 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_00074 | chr3:16439573-16445088 | Adipose_Nuclei | | SE_58304 | chr3:16407941-16571531 | Ly1 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH03I016402 | chr3 | 16444095 | 16444292 |
|
Enhancer Sequence | ATTCTCTTGG TTTGTGGGTG GGTTCTGGTG CAGCAAGCAC AGGAGAGCCT TTTTAACATA 60
ATTTTCATTT CACTCTGAAT TGGCATCTTA CCCTAATTAA AATTAGACTC TCTGCACCGC 120
ACTTGTAGAA ATGAAACTCT GAATACTCAA CAATCAGCCA GAAAGTAAAT GATGAGTCAT 180
TTACATAACA GGCAAAATTT CATCATCCCG GAGATTTGGG ATATTCTGTT TCATTAAAAG 240
AAGCCATTGA GATTTTTCCA TCTGTCAAGG TGCTTTCTTT AGGTTGAGGC ATAAGTAGCA 300
TCATTCGGTT TTCTGAAGGA CAATGTACTC GGTTTAATCC AGGACAGTAC ACTCATTGAG 360
TGGGACCAGC CGCCCCTCAA CGGTCTTCAT TGCAAAGGCT CAGTGGGCCA GTGCAAGATG 420
AACCTAGTTC TTAAGGAGAT CAGGGAGGTC AGGAGCTCCA TCACAAAAGG GAGTCAACTT 480
GGGGAACAGA GCCCAGAGCT GAGGGCCTGA AGGCAAAGGC CACCATGTCT TATCTGGACA 540
AGGGCAGGGA GCGTGGCTTT CTCCCGCAGG CAGGACGAGG CAATTTCCAT CAGCAGAACC 600
TGGGCGGCAA GGGCCTGGAG CCCATCCTTC ACTGAGGGGA CACCTTCAAG GCACTCCAAC 660
ATCTGACCCC ATGTACCCAA CACGCGTTAT GGCCATTTGC CTCCTATGCT CAACCTCACA 720
TTCTGGCTCT GACAGCCTCC ACCTCTGTCC AGAAAGGGAC AAGCTATACA GGAGAGGTAG 780
CATGGCCAAG TGCTCTAGAA CACAGTCCCT GGGTCCAACA GGCTGGGTTC ATATCTCAGT 840
CCTGCCATGC ACAGTTATAA CATTGGCAAA CTGCATAGCT TCTCTGTGTC TCAGTTTCTT 900
CATCTGTCAA ATGAGGATAA GTCTTCACAG GCATGAGATG AGGGTTAAGG GTAGAGTAGA 960
CATGAGCACT TCAGCATAAG GTTTGCCTAA CGCATGAGGA 1000
|
